IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
This Quarter Return
-15.29%
1 Year Return
-10.79%
3 Year Return
-29.46%
5 Year Return
–
10 Year Return
–
AUM
$436M
AUM Growth
+$436M
(+82%)
Cap. Flow
+$221M
Cap. Flow
% of AUM
50.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Coupang
CPNG
|
$225M |
Top Sells
| 1 |
Yext
YEXT
|
$4.61M |
Sector Composition
| 1 | Consumer Discretionary | 51.63% |
| 2 | Healthcare | 41.25% |
| 3 | Technology | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coupang
CPNG
$52.1B
| $225M | 51.63% | +4,564,571 | New | +$225M |
|
2
Arcus Biosciences
RCUS
$1.13B
| $51.7M | 11.86% | 1,842,077 | – | – |
|
|
OYST
3
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $50.6M | 11.6% | 2,768,586 | – | – |
|
4
NovoCure
NVCR
$1.38B
| $46.4M | 10.63% | 350,884 | – | – |
|
|
5
Yext
YEXT
$1.11B
| $31.1M | 7.12% | 2,146,785 -318,523 | -13% | -$4.61M |
|
6
Oric Pharmaceuticals
ORIC
$994M
| $24.7M | 5.66% | 1,007,575 | – | – |
|
|
UBX
7
DELISTED
Unity Biotechnology
UBX
| $6.57M | 1.51% | 1,094,998 | – | – |
|